Market cap
$529.514 M
$20.62 +2.03%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
—
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Investment Managers — ranked by market cap
All 84 →Where these numbers come from
Share counts and financials for abrdn Life Sciences Investors are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.